Zilian Cui
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting the SMAD3/CISD2 axis suppresses bladder cancer progression by promoting ferroptosis in mesenchymal-like bladder cancer cells.
Journal: Cell death & disease
Published: May 09, 2025
Asparagine-linked glycosyltransferase 6 deficiency suppresses tumorigenesis in clear cell renal cell carcinoma by regulating apoptosis and immunotherapy sensitivity.
Journal: Chinese medical journal
Published: December 04, 2024
Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis.
Journal: Cell death & disease
Published: September 02, 2022
Injectable, Adhesive, and Self-Healing Composite Hydrogels Loaded With Oxybutynin Hydrochloride for the Treatment of Overactive Bladder in Rats.
Journal: Frontiers in bioengineering and biotechnology
Published: March 29, 2022
Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.
Journal: Journal of oncology
Published: April 16, 2021
Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence.
Journal: Frontiers in genetics
Published: December 09, 2020
Corrigendum to "The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma".
Journal: BioMed research international
Published: December 05, 2020
LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis.
Journal: Aging
Published: November 28, 2020
Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis.
Journal: Cell death & disease
Published: September 23, 2020
The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Journal: BioMed research international
Published: December 12, 2019
Last Updated: 09/26/2026